NewsWhore
08-16-2010, 02:20 PM
PLX ) and Pfizer Inc. (NYSE: PFE; LSE: PFZ) have signed a $30 million short-term supply agreement in Latin America for Protalix's treatment for Gaucher's disease. The companies did not disclose the na...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/37823834/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/37823834/)